Pregnancy and Paracetamol: Separating Fact from Fiction
The debate surrounding the safety of paracetamol during pregnancy has been a contentious issue, with a recent study providing much-needed clarity. Last year, a controversial claim by former US President Donald Trump sparked global headlines, suggesting a link between paracetamol use in pregnancy and an increased risk of autism in children. However, a comprehensive review published in The Lancet Obstetrics, Gynaecology, & Women’s Health has reinforced the safety of paracetamol when used appropriately.
The systematic review and meta-analysis, which included 43 studies and 17 in the meta-analysis, found no association between taking paracetamol during pregnancy and autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), or intellectual disability in children. The authors emphasized that the study clarifies the previously reported associations in conventional observational studies, which were likely due to residual confounding factors such as maternal illness, fever, genetic susceptibility, or environmental influences, rather than a direct causal effect of paracetamol.
Alex Polyakov, an obstetrician, gynaecologist, fertility specialist, and Clinical Associate Professor at the University of Melbourne, praised the study for offering "timely and methodologically rigorous reassurance." He highlighted the importance of paracetamol in obstetric practice due to its consistent demonstration of the most favorable balance between maternal benefit and fetal safety for managing pain and fever during pregnancy. Polyakov also noted that the public debate had caused understandable anxiety, driven by the selective interpretation of observational data.
The study's authors further emphasized the potential risks of avoiding paracetamol based on inconclusive or biased evidence, which could increase the risk of maternal fever or untreated pain, both of which can harm pregnancy outcomes. They suggested that future research should focus on improving exposure measurement, standardizing outcome definitions, and integrating mechanistic and family-based designs to address any remaining uncertainties.
This comprehensive review comes at a crucial time, as the White House had previously cited several studies suggesting a link between paracetamol during pregnancy and the chances of children being diagnosed with ASD or ADHD. However, many health organizations, including the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, strongly criticized the claim, raising serious doubts about its scientific basis. Some GPs anticipated a surge in patient queries following the US President's remarks, but surprisingly, a survey revealed that most patients had not raised any concerns.
This study serves as a reminder that while medical advice should always be sought from qualified healthcare professionals, it is essential to rely on robust scientific evidence. By separating fact from fiction, we can ensure that pregnant women receive the best possible care and support.
